[HTML][HTML] Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
G Zhou, Q Zhao - International Journal of Biological Sciences, 2020 - ncbi.nlm.nih.gov
A newly identified novel coronavirus (SARS-CoV-2) is causing pneumonia-associated
respiratory syndrome across the world. Epidemiology, genomics, and pathogenesis of the …
respiratory syndrome across the world. Epidemiology, genomics, and pathogenesis of the …
Antibody-mediated neutralization of SARS-CoV-2
Neutralizing antibodies can block infection, clear pathogens, and are essential to provide
long-term immunity. Since the onset of the pandemic, SARS-CoV-2 neutralizing antibodies …
long-term immunity. Since the onset of the pandemic, SARS-CoV-2 neutralizing antibodies …
[HTML][HTML] Fruitful neutralizing antibody pipeline brings hope to defeat SARS-Cov-2
With the recent spread of severe acute respiratory syndrome coronavirus (SARS-CoV-2) _
infecting> 16 million people worldwide as of 28 July 2020, causing> 650 000 deaths, there …
infecting> 16 million people worldwide as of 28 July 2020, causing> 650 000 deaths, there …
[HTML][HTML] Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617
Abstract COVID-19 pathogen SARS-CoV-2 has infected hundreds of millions and caused
over 5 million deaths to date. Although multiple vaccines are available, breakthrough …
over 5 million deaths to date. Although multiple vaccines are available, breakthrough …
Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants
F Wang, L Li, Y Dou, R Shi, X Duan, H Liu… - Emerging Microbes & …, 2022 - Taylor & Francis
The neutralizing antibody is a potential therapeutic for the ongoing COVID-19 pandemic. As
an antiviral agent, numerous mAbs recognize the epitopes that overlap with ACE2-binding …
an antiviral agent, numerous mAbs recognize the epitopes that overlap with ACE2-binding …
Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including BQ. 1.1, CA. 3.1, CH. 1.1, XBB. 1.16, and XBB. 1.5
KC Entzminger, JK Fleming, PD Entzminger… - Antibody …, 2023 - academic.oup.com
Abstract SARS-CoV-2 Omicron variant XBB. 1.5 has shown extraordinary immune escape
even for fully vaccinated individuals. There are currently no approved antibodies that …
even for fully vaccinated individuals. There are currently no approved antibodies that …
[HTML][HTML] Neutralizing and enhancing antibodies against SARS-CoV-2
Y Liu, H Arase - Inflammation and Regeneration, 2022 - Springer
The high transmissibility and rapid global spread of SARS-CoV-2 since 2019 has led to a
huge burden on healthcare worldwide. Anti-SARS-CoV-2 neutralizing antibodies play an …
huge burden on healthcare worldwide. Anti-SARS-CoV-2 neutralizing antibodies play an …
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
Antibodies against coronavirus spike protein potently protect against infection and disease,
but whether such protection can be extended to variant coronaviruses is unclear. This is …
but whether such protection can be extended to variant coronaviruses is unclear. This is …
[HTML][HTML] A potent and protective human neutralizing antibody against SARS-CoV-2 variants
S Shan, CK Mok, S Zhang, J Lan, J Li, Z Yang… - Frontiers in …, 2021 - frontiersin.org
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to
emerge and spread around the world, antibodies and vaccines to confer broad and potent …
emerge and spread around the world, antibodies and vaccines to confer broad and potent …
[HTML][HTML] Broadly-neutralizing antibodies against emerging SARS-CoV-2 variants
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
have become a major concern in the containment of current pandemic. The variants …
have become a major concern in the containment of current pandemic. The variants …